We are live on
!
Find out more
RXII
GALENA BIOPHARMA INC COM
RXII
RXII
Delisted
RXII was delisted on the 25th of October, 2011.
Fund managers haven’t disclosed any holdings of RXII yet.
RXII Hedge Fund Activity: Q4 2016 in Review
0 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q4 2016, worth a combined $0 — down 100% from $11.5M a quarter earlier.
Sellers outnumbered buyers: 90 funds closed out of RXII and 0 opened new positions — a net loss of 90 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $2.93M sold.
- 0 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q4 2016, down from 91 in Q3 2016.
- Funds reported $0 of GALENA BIOPHARMA INC COM stock for Q4 2016, down 100% quarter-over-quarter.
- 0 funds opened new GALENA BIOPHARMA INC COM positions in Q4 2016 and 90 closed out, a net change of -90 holders.
- The largest GALENA BIOPHARMA INC COM seller in Q4 2016 was Vanguard Group, an estimated $2.93M sold.
Based on aggregated 13F filings for Q4 2016.